QUARTI TREVANO FOSCA ANNA LUISA

Grassi, G., Cuspidi, C., Dell'Oro, R., Quarti-Trevano, F. (2025). Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION [10.1007/s40292-025-00716-x]. Detail

D'Elia, L., Masulli, M., Virdis, A., Casiglia, E., Tikhonoff, V., Angeli, F., et al. (2025). Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project). THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 110(2 (1 February 2025)), 470-477 [10.1210/clinem/dgae170]. Detail

Russo, E., Viazzi, F., Pontremoli, R., Angeli, F., Barbagallo, C., Berardino, B., et al. (2025). Predictive value of TG/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study. LIPIDS IN HEALTH AND DISEASE, 24(1) [10.1186/s12944-025-02440-w]. Detail

Mancia, G., Facchetti, R., Quarti-Trevano, F., Grassi, G. (2025). Reproducibility and Treatment Effect on Office and Ambulatory Pressure Relation. HYPERTENSION, 82(1 (January 2025)), 126-135 [10.1161/hypertensionaha.124.23549]. Detail

Fosca, Q., Grassi, G. (2025). Renal Denervation. In A.E. Berbari, G. Mancia, J. Redon (a cura di), Blood pressure disorders in acute and chronic kidney disease (pp. 367-375). Springer [10.1007/978-3-031-81292-7_17]. Detail